KalVista Pharmaceuticals: Sebetralstat Success Eyes FDA Approvalby Mark Eisenberg 13.02.2024KalVista Pharmaceuticals achieves key goals in late-stage study for hereditary angioedema therapy, demonstrating significant efficacy of sebetralstat. FDA approval filing ...